BRIMONIDINE TARTRATE Recall D-0433-2023
Description: Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1, UPC 3 60505 05641 5; b) 10 mL dropper bottle NDC 60505-0564-2, UPC 3 60505 05642 2; c) 15 mL dropper bottle, NDC 60505-0564-3, UPC 3 60505 05643 9; Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326
BRIMONIDINE TARTRATE Recall D-0433-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0433-2023 |
Event ID | 91803 |
Brand | BRIMONIDINE TARTRATE |
Generic Name | BRIMONIDINE TARTRATE |
Manufacturer | BRIMONIDINE TARTRATE |
Original Package? | 1 |
Active Substance | BRIMONIDINE TARTRATE |
Drug Route | OPHTHALMIC |
Distribution | Nationwide in the USA |
Quantity | 67,056 bottles |
Recall Reason | Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility. |
Drug Classification | Class II |
Drug Code Info | 20230315 |
Product NDC | 60505-0564 |
Drug UPC | 360505056415 360505056422 360505056439 |
Recall Initiation Date | 20230301 |
Report Date | 20230315 |
Classification Date | 20230303 |
Address | 2400 N Commerce Pkwy Ste 400 Weston, FL 33326-3253 United States |
Recalling Firm | Apotex Corp. |
Initial Notification | Press Release |
Unique Ingredient Identifier | 4S9CL2DY2H |
Drug Application Number | ANDA078479 |
Structured Product Labeling (SPL ID) | 566ae0f8-fdea-33ec-d315-2d2376805ab1 |
Structured Product Labeling (SPL Set ID) | 64b21e68-610c-5194-ccb2-9d9f6ff8cda9 |
Similar To |